News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Meckler Jeffrey A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 13,500 options to buy
@ $17.11, valued at
$231k
|
|
| 01/20/2023 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.61, valued at
$161k
|
|
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2022 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 10,308 shares
@ $2.8, valued at
$28.9k
|
|
| 09/08/2022 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 1,060 shares
@ $2.44, valued at
$2.6k
Bought 8,632 shares
@ $2.57, valued at
$22.2k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $4.9, valued at
$980k
|
|
| 11/19/2021 |
4
| Meckler Jeffrey A (CEO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Bought 11,187 shares
@ $5.82, valued at
$65.1k
|
|
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 9,000 options to buy
@ $15.43, valued at
$138.9k
|
|
| 08/29/2019 |
4
| Meckler Jeffrey A (CEO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Bought 20,000 shares
@ $0.681, valued at
$13.6k
|
|
| 08/27/2019 |
4
| Meckler Jeffrey A (CEO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Bought 100,000 shares
@ $0.457, valued at
$45.7k
|
|
| 05/10/2019 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,000 shares
@ $0
Granted 8,000 options to buy
@ $17.94, valued at
$143.5k
|
|
| 04/05/2019 |
4
| Meckler Jeffrey A (CEO) has filed a Form 4 on Intec Pharma Ltd.|
Txns:
| Granted 125,000 options to buy
@ $7.64, valued at
$955k
|
|
| 05/11/2018 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,500 shares
@ $0
Granted 10,000 options to buy
@ $26.52, valued at
$265.2k
|
|
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2016 |
4
| Meckler Jeffrey A (CEO) has filed a Form 4 on Cocrystal Pharma, Inc.|
Txns:
| Bought 294,118 shares
@ $0.51, valued at
$150k
|
|
| 03/07/2016 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Bought 5,000 shares
@ $15.3129, valued at
$76.6k
|
|
| 07/17/2013 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on QLT INC/BC|
Txns:
| Granted 11,000 options to buy
@ $0
Granted 6,000 restricted stock units
@ $0
Granted 12,500 options to buy
@ $0 |
|
| 05/06/2013 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on QLT INC/BC|
Txns:
| Bought 20,000 shares
@ $7.96, valued at
$159.2k
|
|
| 07/12/2012 |
4
| Meckler Jeffrey A (Director) has filed a Form 4 on QLT INC/BC|
Txns:
| Granted 11,000 options to buy
@ $0 |
|
|
|